France Inhibitors Research
14 comprehensive market analysis studies and research reports on the France Inhibitors sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 116 companies, enriched with industry statistics, insights, and a lot more.

TRENDING REPORTS
Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 3.80%
Study Period : 2019 - 2030
North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 0.9%
Study Period : 2021 - 2030
MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market
CAGR: 9.15%
Study Period : 2019 - 2030
Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 4.30%
Study Period : 2019 - 2030
North America Alpha-Glucosidase Inhibitors Market
CAGR: 2.5%
Study Period : 2019 - 2030
Healthcare
Categories
14 Healthcare Reports
Categories
Showing 14 of 14 results in Inhibitors
Tyrosine Kinase Inhibitors Market
CAGR: 8.37%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Boehringer Ingelheim, Roche, AstraZeneca, Novartis, Bayer
PD-1 And PD-L1 Inhibitors Market
CAGR: 14.15%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Bristol-Myers Squibb, Merck, Roche, Pfizer, GlaxoSmithKline
Europe Alpha-Glucosidase Inhibitors Market
CAGR: 2.20%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Takeda Pharmaceuticals, Pfizer, Bayer, Sun Pharmaceuticals Industries, Glenmark Pharmaceuticals
TRENDING REPORTS
Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 3.80%
Study Period : 2019 - 2030
North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 0.9%
Study Period : 2021 - 2030
MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market
CAGR: 9.15%
Study Period : 2019 - 2030
Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 4.30%
Study Period : 2019 - 2030
North America Alpha-Glucosidase Inhibitors Market
CAGR: 2.5%
Study Period : 2019 - 2030
Enzyme Inhibitors Market
CAGR: 3.95%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Abbott Laboratories, AstraZeneca, Bayer, Boehringer Ingelheim, Amgen
Global Interleukin Inhibitors Market
CAGR: 12.5%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Abbvie, Johnson & Johnson, Novartis, Eli Lilly and Company, GlaxoSmithKline
Esomeprazole Market
CAGR: 6.16%
Study Period: 2021 - 2030
Country Covered: France
Major Players:Teva Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Daiichi Sankyo, Sun Pharmaceuticals Industries
Imatinib Drug Market
CAGR: 3%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Sun Pharmaceuticals Industries, Novartis, Teva Pharmaceutical Industries, Mylan, Dr. Reddy’s Laboratories
Immune Checkpoint Inhibitors Market
CAGR: 16.49%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Bristol-Myers Squibb, Regeneron Pharmaceuticals, Roche, AstraZeneca, Merck
TNF Inhibitors Market
CAGR: 3.59%
Study Period: 2019 - 2030
Country Covered: France
Major Players:UCB, Pfizer, Johnson & Johnson, Amgen, Abbvie
Plasma Protease C1-inhibitor Market
CAGR: 9.63%
Study Period: 2019 - 2030
Country Covered: France
Major Players:CSL Behring, Takeda Pharmaceuticals, Pharming Technologies B.V., KalVista Pharmaceuticals, BioCryst Pharmaceuticals
Alpha-glucosidase Inhibitors Market
CAGR: 2.17%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Sun Pharmaceuticals Industries, Bayer, Takeda Pharmaceuticals, Torrent Pharmaceuticals, Pfizer
Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 2.78%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Merck, AstraZeneca, Boehringer Ingelheim, Pfizer, Eli Lilly and Company
Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
CAGR: 2.73%
Study Period: 2019 - 2030
Country Covered: France
Major Players:AstraZeneca, Takeda Pharmaceuticals, Novartis, Merck, Eli Lilly and Company
Proton Pump Inhibitors Market
CAGR: 5.14%
Study Period: 2019 - 2030
Country Covered: France
Major Players:Bayer, Pfizer, Takeda Pharmaceuticals, Zydus Group, AstraZeneca
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.












